The Allstate Co. (NYSE:ALL) Short Interest Update

The Allstate Co. (NYSE:ALL) saw a significant growth in short interest in October. As of October 15th, there was short interest totalling 2,210,000 shares, a growth of 27.0% from the September 30th total of 1,740,000 shares. Based on an average daily volume of 1,500,000 shares, the days-to-cover ratio is currently 1.5 days. Currently, 0.8% of the company’s stock are sold short.

Insider Activity at Allstate

In other Allstate news, CEO Thomas J. Wilson sold 90,000 shares of the stock in a transaction on Wednesday, August 21st. The stock was sold at an average price of $179.34, for a total value of $16,140,600.00. Following the completion of the transaction, the chief executive officer now owns 88,552 shares in the company, valued at approximately $15,880,915.68. This represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. In other news, CEO Thomas J. Wilson sold 90,000 shares of Allstate stock in a transaction that occurred on Wednesday, August 21st. The shares were sold at an average price of $179.34, for a total transaction of $16,140,600.00. Following the completion of the transaction, the chief executive officer now directly owns 88,552 shares in the company, valued at approximately $15,880,915.68. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, EVP Robert Toohey sold 16,682 shares of Allstate stock in a transaction on Monday, August 19th. The shares were sold at an average price of $180.17, for a total value of $3,005,595.94. Following the transaction, the executive vice president now owns 4,873 shares of the company’s stock, valued at $877,968.41. The trade was a 0.00 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 192,530 shares of company stock worth $34,967,665 over the last ninety days. 1.80% of the stock is owned by corporate insiders.

Institutional Trading of Allstate

Several institutional investors and hedge funds have recently modified their holdings of the company. Northwest Investment Counselors LLC bought a new stake in Allstate during the 3rd quarter valued at approximately $28,000. Versant Capital Management Inc boosted its position in shares of Allstate by 70.9% during the second quarter. Versant Capital Management Inc now owns 188 shares of the insurance provider’s stock worth $30,000 after acquiring an additional 78 shares during the last quarter. Family Firm Inc. purchased a new position in Allstate during the second quarter valued at $38,000. MCF Advisors LLC increased its holdings in Allstate by 33.9% in the 2nd quarter. MCF Advisors LLC now owns 332 shares of the insurance provider’s stock valued at $53,000 after acquiring an additional 84 shares during the last quarter. Finally, Sunbelt Securities Inc. lifted its stake in Allstate by 38.5% in the 1st quarter. Sunbelt Securities Inc. now owns 363 shares of the insurance provider’s stock worth $63,000 after purchasing an additional 101 shares in the last quarter. 76.47% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

Several research analysts have recently issued reports on the stock. Jefferies Financial Group upped their target price on shares of Allstate from $217.00 to $231.00 and gave the stock a “buy” rating in a research note on Wednesday, October 9th. Piper Sandler lifted their target price on Allstate from $188.00 to $196.00 and gave the stock an “overweight” rating in a report on Friday, August 16th. UBS Group lifted their price objective on Allstate from $215.00 to $216.00 and gave the stock a “buy” rating in a report on Tuesday, October 15th. Keefe, Bruyette & Woods upped their target price on shares of Allstate from $199.00 to $208.00 and gave the company an “outperform” rating in a research note on Monday, August 12th. Finally, Roth Mkm reiterated a “buy” rating and issued a $200.00 price target on shares of Allstate in a research note on Wednesday, August 14th. One investment analyst has rated the stock with a sell rating, two have given a hold rating, thirteen have given a buy rating and one has assigned a strong buy rating to the company’s stock. According to data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus target price of $206.44.

Allstate Trading Down 1.4 %

NYSE:ALL opened at $186.55 on Wednesday. The firm has a market capitalization of $49.23 billion, a price-to-earnings ratio of 41.18, a price-to-earnings-growth ratio of 1.74 and a beta of 0.48. The company has a debt-to-equity ratio of 0.49, a current ratio of 0.36 and a quick ratio of 0.36. The business has a fifty day moving average price of $188.48 and a 200-day moving average price of $174.85. Allstate has a one year low of $123.42 and a one year high of $198.79.

Allstate (NYSE:ALL) last released its earnings results on Wednesday, July 31st. The insurance provider reported $1.61 EPS for the quarter, topping analysts’ consensus estimates of $0.33 by $1.28. The company had revenue of $15.71 billion for the quarter, compared to analysts’ expectations of $14.04 billion. Allstate had a net margin of 5.03% and a return on equity of 24.05%. The firm’s revenue was up 12.4% compared to the same quarter last year. During the same quarter last year, the business earned ($4.42) EPS. Sell-side analysts forecast that Allstate will post 15.19 EPS for the current year.

About Allstate

The Allstate Corporation, together with its subsidiaries, provides property and casualty, and other insurance products in the United States and Canada. It operates in five segments: Allstate Protection; Protection Services; Allstate Health and Benefits; Run-off Property-Liability; and Corporate and Other segments.